Wednesday, October 04, 2017 7:24:48 PM
Suggest you read the vascular surgical article I linked previously
The best results were seen in the radiocephalic AVF's at 30ug .....and everyone in this final trial will have radio AVF's treated with the 30ug dose
Note tho ...the P value for this subgroup was .046 ...so barely stat sig.
IMHO it won't require a lot of benefit , to make this treatment clinically significant , as it can be done in seconds during fistula creation at a cost of about $600
Data read out is not till Q1 2019 .....next important data pt is probably when they announce full enrollment .
. Separation in event lines occurs fairly fast in the 30ug dose of radio AVF's. Most of these , early on , were done at UCSF where I'm sure their data base tracks patencey failure rates in all their dialysis patients ....so I'm wondering if they are seeing any change in overall failure rates since they started this program
Kiwi
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM